title: Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation.
abstract: BACKGROUND
  Ecto-5'-nucleotidase (NT5E, also known as CD73) hydrolyzes extracellular adenosine 5'-monophosphate (AMP) to adenosine in nociceptive circuits. Since adenosine has antinociceptive effects in rodents and humans, we hypothesized that NT5E, an enzyme that generates adenosine, might also have antinociceptive effects in vivo.
  
  
  RESULTS
  To test this hypothesis, we purified a soluble version of mouse NT5E (mNT5E) using the baculovirus expression system. Recombinant mNT5E hydrolyzed AMP in biochemical assays and was inhibited by alpha,beta-methylene-adenosine 5'-diphosphate (alpha,beta-me-ADP; IC50 = 0.43 microM), a selective inhibitor of NT5E. mNT5E exhibited a dose-dependent thermal antinociceptive effect that lasted for two days when injected intrathecally in wild-type mice. In addition, mNT5E had thermal antihyperalgesic and mechanical antiallodynic effects that lasted for two days in the complete Freund's adjuvant (CFA) model of inflammatory pain and the spared nerve injury (SNI) model of neuropathic pain. In contrast, mNT5E had no antinociceptive effects when injected intrathecally into adenosine A1 receptor (A1R, Adora1) knockout mice.
  
  
  CONCLUSIONS
  Our data indicate that the long lasting antinociceptive effects of mNT5E are due to hydrolysis of AMP followed by activation of A1R. Moreover, our data suggest recombinant NT5E could be used to treat chronic pain and to study many other physiological processes that are regulated by NT5E.
authors.affiliation: Department of Cell and Molecular Physiology, UNC Neuroscience Center, University of North Carolina, CB #7545, Chapel Hill, North Carolina 27599, USA.
authors.forename: Nathaniel A
authors.initials: NA
authors.lastname: Sowa
authors.forename: Meagen K
authors.initials: MK
authors.lastname: Voss
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Zylka
mesh_terms: D015720:5'-Nucleotidase / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use*; D000249:Adenosine Monophosphate / Q000378:metabolism; D000700:Analgesics / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010146:Pain / Q000188:drug therapy; D043682:Receptor, Adenosine A1 / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D043682:Receptor, Adenosine A1; D011994:Recombinant Proteins; D000249:Adenosine Monophosphate; D015720:5'-Nucleotidase
references.citation: Pain. 2003 Jan;101(1-2):129-38
references.pmid: 12507707
references.citation: Prog Neurobiol. 2003 Apr;69(5):313-40
references.pmid: 12787573
references.citation: Neuron. 2008 Oct 9;60(1):111-22
references.pmid: 18940592
references.citation: PLoS One. 2009;4(1):e4248
references.pmid: 19158948
references.citation: Nat Rev Drug Discov. 2006 Mar;5(3):247-64
references.pmid: 16518376
references.citation: Braz J Med Biol Res. 2004 Mar;37(3):401-7
references.pmid: 15060710
references.citation: Handb Exp Pharmacol. 2007;(177):309-28
references.pmid: 17087128
references.citation: Biochem J. 1992 Jul 15;285 ( Pt 2):345-65
references.pmid: 1637327
references.citation: J Mol Biol. 1999 Sep 24;292(3):741-58
references.pmid: 10497036
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9407-12
references.pmid: 11470917
references.citation: Mol Endocrinol. 1991 Aug;5(8):1037-48
references.pmid: 1658635
references.citation: Anesthesiology. 2007 Nov;107(5):797-806
references.pmid: 18073555
references.citation: Expert Opin Investig Drugs. 2000 Mar;9(3):551-64
references.pmid: 11060695
references.citation: J Pain. 2003 Oct;4(8):465-70
references.pmid: 14622667
references.citation: J Clin Invest. 2004 Sep;114(5):634-42
references.pmid: 15343381
references.citation: Pain. 2003 Sep;105(1-2):65-70
references.pmid: 14499421
references.citation: Anesth Analg. 1999 Jul;89(1):136-42
references.pmid: 10389791
references.citation: J Neurosci. 1997 Jan 15;17(2):735-44
references.pmid: 8987795
references.citation: Anesthesiology. 1999 Oct;91(4):1072-9
references.pmid: 10519511
references.citation: Gastroenterology. 2008 Nov;135(5):1739-1750.e3
references.pmid: 18804111
references.citation: J Neurosci. 2010 Feb 10;30(6):2235-44
references.pmid: 20147550
references.citation: Anesth Analg. 2005 Nov;101(5):1417-1421
references.pmid: 16244004
references.citation: J Anesth. 2005;19(3):225-35
references.pmid: 16032451
references.citation: Adv Drug Deliv Rev. 2003 Aug 28;55(8):1007-41
references.pmid: 12935942
references.citation: Neuroscience. 2003;121(4):907-16
references.pmid: 14580941
references.citation: Anesth Analg. 1995 Apr;80(4):844-7
references.pmid: 7893048
references.citation: Life Sci. 1992;51(19):PL171-6
references.pmid: 1435056
references.citation: J Pharm Pharmacol. 1983 Oct;35(10):679-80
references.pmid: 6139442
references.citation: Pain. 1995 Apr;61(1):155-158
references.pmid: 7644239
references.citation: Eur J Pharmacol. 1995 Nov 14;286(2):177-84
references.pmid: 8605954
references.citation: Neurosci Lett. 1997 Feb 28;223(3):173-6
references.pmid: 9080460
references.citation: Purinergic Signal. 2007 Jun;3(3):233-46
references.pmid: 18404437
references.citation: Pain. 2003 May;103(1-2):111-7
references.pmid: 12749965
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L25-32
references.pmid: 17468137
references.citation: J Exp Med. 2003 Sep 1;198(5):783-96
references.pmid: 12939345
references.citation: Pain. 1988 Jan;32(1):77-88
references.pmid: 3340425
references.citation: Anal Biochem. 1979 Nov 15;100(1):95-7
references.pmid: 161695
references.citation: J Exp Med. 2004 Dec 6;200(11):1395-405
references.pmid: 15583013
references.citation: J Pain. 2008 Feb;9(2):174-84
references.pmid: 18088557
references.citation: Pain. 1999 Mar;80(1-2):31-6
references.pmid: 10204715
references.citation: J Immunol. 2007 Jun 15;178(12):8127-37
references.pmid: 17548651
references.citation: Pharmacol Ther. 2005 Jul;107(1):1-30
references.pmid: 15963349
references.citation: Pain. 2005 Feb;113(3):395-404
references.pmid: 15661449
references.citation: Pharmacol Biochem Behav. 2002 Oct;73(3):573-81
references.pmid: 12151032
references.citation: Circ Res. 2004 Oct 15;95(8):814-21
references.pmid: 15358667
references.citation: Pain. 2007 Oct;131(3):281-292
references.pmid: 17317007
references.citation: Anesthesiology. 2002 Jan;96(1):29-34
references.pmid: 11752998
references.citation: J Pharmacol Exp Ther. 1996 Jun;277(3):1642-8
references.pmid: 8667233
references.citation: Nat Med. 2004 Jul;10(7):712-8
references.pmid: 15195086
references.citation: Purinergic Signal. 2006 Jun;2(2):351-60
references.pmid: 18404475
references.citation: Pain. 1998 Feb;74(2-3):235-45
references.pmid: 9520238
references.citation: Biochemistry. 1990 Aug 28;29(34):7923-7
references.pmid: 2148114
references.citation: J Clin Invest. 1997 Jun 1;99(11):2588-601
references.pmid: 9169488
references.citation: Cephalalgia. 2003 May;23(4):287-92
references.pmid: 12716347